Quintiles has appointed Oren Cohen (pictured) is its new Senior Vice President and Global Head of its Phase I Clinical Research division.
Mr Cohen has been promoted from his position as Chief Medical and Scientific Officer (CMSO) and will leverage the company’s clinical trial services and deep expertise in biomarker development.
Paula Brown Stafford, President of Quintiles Clinical Development, says Mr Cohen brings a “wealth of clinical and scientific expertise” after his former roles at the company.
The former medical advisor joined the company back in 2001 and was appointed CMSO in 2004.
“The Phase I clinical research space is changing rapidly, with fewer new molecules entering development and a fundamental shift in target study populations from healthy volunteers to patient groups,” said Mr Cohen.
“Biopharma companies are looking for an ally to help them manage these complexities, ensure patient safety and reduce costs, and Quintiles offers best-in-class early clinical development solutions to meet our customers’ needs.”